Crossroads Health Ventures
Crossroads Health Ventures is an Indianapolis-based, early-stage venture capital firm investing in U.S. life sciences startups, sponsored by BioCrossroads within the CICP ecosystem. It deploys capital aligned with strategic LP priorities and supplements investment with introductions to a network of 100+ corporations.
- Company typePrivate
- Founded2026
- HeadquartersIndianapolis, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Crossroads Health Ventures does
Crossroads Health Ventures (CHV) is an early-stage venture capital firm that invests in U.S.-based life sciences startups, with operational roots in Indianapolis, Indiana, and structural sponsorship from BioCrossroads within the Central Indiana Corporate Partnership (CICP) ecosystem. The firm targets pre-seed and early-stage life sciences companies whose strategic fit aligns with the priorities of its limited partners, and supplements capital with curated introductions to the CICP network of more than 100 corporations — a distribution differentiator that the firm positions as its primary value-add beyond pure financial investment. CHV's stated investment criteria are explicit: life sciences sector innovation, early-stage U.S.-based companies, and alignment with strategic LPs.
The firm operates a single unified offering — early-stage life sciences venture investment — supported by an inbound Startup Inquiry Form (crossroadshealthventures.com/chv-form/) as the primary capital-deployment channel and an outbound sourcing motion via the CICP, BioCrossroads, TechPoint (Indiana Founders Network), and AgriNovus Indiana ecosystem. There is no proprietary technology platform, AI/ML infrastructure, or API; the underlying "product" is fund economics (management fees and carried interest on equity appreciation in portfolio companies). Revenue mechanics, fund size, ticket sizes, and management fee structures are not publicly disclosed.
CHV is led by Managing Directors Ting Gootee (also EVP Digital Adoption at CICP; CFA, CAIA) and Vince Wong (JD, MBA), alongside Principal Samantha Ginther (MPH), and is operationally supported by senior figures embedded in BioCrossroads (Emily Atkinson, PhD), TechPoint (Chelsea Linder), and AgriNovus Indiana (Christy Wright). The team holds dual roles across the Indiana life sciences ecosystem, which reinforces the firm's deal-sourcing and value-add capabilities but also signals that CHV is, at present, more of a coordinated initiative within an existing ecosystem than a standalone institutional asset manager.
Crossroads Health Ventures firmographics
Firmographics- Name
- Crossroads Health Ventures
- Legal name
- Crossroads Health Ventures
- Website
- https://crossroadshealthventures.com
- Company type
- Private
- Founded year
- 2026
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Crossroads Health Ventures is an Indianapolis-based, early-stage venture capital firm investing in U.S. life sciences startups, sponsored by BioCrossroads within the CICP ecosystem. It deploys capital aligned with strategic LP priorities and supplements investment with introductions to a network of 100+ corporations.
- Ownership category
- akta.pro rank
Crossroads Health Ventures industry classification
Industry- Product category
- Life Sciences Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940)
- akta.pro primary industry
- Captive CVC Fund (Dedicated corporate fund structure) (FSANAHAB)
- akta.pro secondary industry
- Corporate Innovation & Technology Scouting Units (with investment mandate) (FSANAHAI)
Keywords
Where Crossroads Health Ventures is headquartered
LocationHeadquarters
- HQ city
- Indianapolis
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Crossroads Health Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Venture investment returns (capital gains / fund economics): As a venture fund investing in early-stage, U.S.-based life sciences companies aligned with strategic LPs, CHV generates returns through equity appreciation in portfolio companies and typical fund economics (management fees and carried interest on successful exits). No specific fee schedule or return figures are publicly disclosed.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Crossroads Health Ventures product offering
Product offeringCore offering
Crossroads Health Ventures (CHV) is an early-stage venture capital firm that invests in U.S.-based life sciences startups aligned with strategic limited partners within the Central Indiana Corporate Partnership (CICP) network. The fund provides early-stage capital along with curated corporate introductions and strategic guidance drawn from a network of 100+ corporations and 300+ startups supported annually through CICP.
Product overview
Crossroads Health Ventures (CHV) operates a single unified venture investment offering rather than a platform-plus-modules product architecture. Its core offering is early-stage, U.S.-based life sciences investing for founders, with support layered on through the Central Indiana Corporate Partnership (CICP) network. The CHV Inquiry Form serves as a sub-product/intake tool, enabling prospective portfolio startups to submit inquiries directly to the CHV team via the website.
Differentiator
Problem solved
Functional benefit
Products and services
- Crossroads Health Ventures (CHV) Early-Stage Life Sciences Investment Program Early-stage venture capital investment program for U.S.-based life sciences startups, providing capital aligned with strategic LPs and access to the CICP network of 100+ corporations for strategic guidance and introductions.
Quantifiable outcome
- 300+ startups supported annually through the CICP network
- +1 more outcomes
Companies that use Crossroads Health Ventures
Customer profileSegments2 records
Ideal customer profiles2 records
Crossroads Health Ventures technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Crossroads Health Ventures partnerships and signals
Strategic signalScale indicators4 records
Recent moves5 records
Expansion highlights5 records
Crossroads Health Ventures competitors and assessment
Company assessmentDirect peers
- Lux Capital: Early-stage venture firm with deep life sciences and biotech investing alongside frontier tech. Comparable to CHV in early-stage, science-heavy investment philosophy and U.S. deployment mandate.
- ARCH Venture Partners: Premier U.S. life sciences venture firm investing across biotech, genomics, and health tech from seed through growth. Comparable as a specialized life sciences VC, though significantly larger and more established than CHV.
- Section 32: Venture fund investing at the frontier of technology, healthcare, and life sciences. Comparable to CHV as an early-stage, thesis-driven life sciences investor, though with substantially larger fund size.
- Atlas Venture: Early-stage life sciences venture firm focused on building biotech startups. Directly comparable to CHV in stage focus (seed/early) and life sciences specialization, though with a far longer track record.
Regional players
- BioGenerator: St. Louis-based seed and early-stage life sciences investor and startup creator. Closest comparable to CHV as a regional life sciences venture platform operating within a state-level innovation ecosystem.
- Elevate Ventures: Indiana-focused early-stage venture fund and ecosystem builder. Closely comparable to CHV as an Indiana-rooted, ecosystem-anchored early-stage investor, though broader across sectors beyond life sciences.
Broad incumbents
- Flagship Pioneering: Large life sciences innovation platform that originates and funds biotech companies. Comparable as a life sciences-focused venture creator, though operating at vastly greater scale and with proprietary origination methods.
- Khosla Ventures: Large U.S. venture firm with a meaningful life sciences and healthcare practice. Comparable as an early-stage investor in science-driven companies, though operating across many sectors at much greater scale.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Crossroads Health Ventures social profiles
Digital presenceCrossroads Health Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
Crossroads Health Ventures leadership team
Management profileNumber of profiles
Profiles6 records
Crossroads Health Ventures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Crossroads Health Ventures M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Crossroads Health Ventures
What does Crossroads Health Ventures do?
Crossroads Health Ventures (CHV) is an early-stage venture capital firm that invests in U.S.-based life sciences startups aligned with strategic limited partners within the Central Indiana Corporate Partnership (CICP) network. The fund provides early-stage capital along with curated corporate introductions and strategic guidance drawn from a network of 100+ corporations and 300+ startups supported annually through CICP.
Is Crossroads Health Ventures a public or private company?
Crossroads Health Ventures is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Crossroads Health Ventures founded?
Crossroads Health Ventures was founded in 2026. It employs 1 to 10 people.
Where is Crossroads Health Ventures based?
Crossroads Health Ventures is headquartered in Indianapolis, United States, in the North America region.
How does Crossroads Health Ventures make money?
One revenue line is on record: venture investment returns (capital gains / fund economics).
Who are Crossroads Health Ventures's main competitors?
Direct peers on record are Lux Capital, ARCH Venture Partners, Section 32 and Atlas Venture. Regional players are BioGenerator and Elevate Ventures. Broad incumbents are Flagship Pioneering and Khosla Ventures.
Does Crossroads Health Ventures have an API?
No public API is recorded for Crossroads Health Ventures.
What industry is Crossroads Health Ventures in?
Crossroads Health Ventures's product category is Life Sciences Venture Capital. Its primary akta.pro industry code is FSANAHAB, Captive CVC Fund (Dedicated corporate fund structure), with a secondary code of FSANAHAI, Corporate Innovation & Technology Scouting Units (with investment mandate). Its NAICS code is 523940.